• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).慢性肾脏病与常见的心房颤动:慢性肾脏病预后队列研究(CRIC)。
Am Heart J. 2010 Jun;159(6):1102-7. doi: 10.1016/j.ahj.2010.03.027.
2
Comparison of atrial fibrillation in CKD and non-CKD populations: A cross-sectional analysis from the Kailuan study.慢性肾脏病与非慢性肾脏病人群中心房颤动的比较:来自开滦研究的横断面分析。
Int J Cardiol. 2019 Feb 15;277:125-129. doi: 10.1016/j.ijcard.2018.11.098. Epub 2018 Nov 17.
3
Prediction of Incident Atrial Fibrillation in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study.慢性肾脏病患者中房颤事件的预测:慢性肾功能不全队列研究。
Clin J Am Soc Nephrol. 2021 Jul;16(7):1015-1024. doi: 10.2215/CJN.01060121. Epub 2021 Jul 12.
4
Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.美国成年人慢性肾脏病与心房颤动的相关性:卒中地理和种族差异原因(REGARDS)研究。
Circ Arrhythm Electrophysiol. 2011 Feb;4(1):26-32. doi: 10.1161/CIRCEP.110.957100. Epub 2010 Nov 13.
5
Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.成人慢性肾脏病患者的阵发心房颤动与终末期肾病风险。
Circulation. 2013 Feb 5;127(5):569-74. doi: 10.1161/CIRCULATIONAHA.112.123992. Epub 2012 Dec 28.
6
Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.慢性肾脏病患者新发心房颤动后的心血管事件:慢性肾功能不全队列(CRIC)研究结果。
J Am Soc Nephrol. 2018 Dec;29(12):2859-2869. doi: 10.1681/ASN.2018050514. Epub 2018 Oct 30.
7
Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.肾功和房颤导管消融患者的预后:广州房颤消融登记研究。
Arch Cardiovasc Dis. 2019 Jun-Jul;112(6-7):420-429. doi: 10.1016/j.acvd.2019.02.006. Epub 2019 May 25.
8
Atrial Fibrillation and Risk of ESRD in Adults with CKD.慢性肾脏病成人患者的心房颤动与终末期肾病风险
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1189-1196. doi: 10.2215/CJN.10921015. Epub 2016 Apr 12.
9
Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.慢性肾脏病成年患者的种族/族裔与心血管结局:慢性肾功能不全队列(CRIC)研究及西班牙裔CRIC研究的结果
Am J Kidney Dis. 2016 Oct;68(4):545-553. doi: 10.1053/j.ajkd.2016.03.429. Epub 2016 May 19.
10
Interatrial block, P terminal force or fragmented QRS do not predict new-onset atrial fibrillation in patients with severe chronic kidney disease.房间传导阻滞、P 波终末电势或碎裂 QRS 波不能预测严重慢性肾脏病患者新发心房颤动。
BMC Cardiovasc Disord. 2020 Oct 7;20(1):437. doi: 10.1186/s12872-020-01719-3.

引用本文的文献

1
Ubiquitin-specific protease 38 modulates atrial fibrillation susceptibility in chronic kidney disease via STRAP stabilization and activation of TGF-β/SMAD signaling.泛素特异性蛋白酶38通过稳定STRAP和激活TGF-β/SMAD信号通路调节慢性肾脏病患者的房颤易感性。
Mol Med. 2025 Jun 13;31(1):238. doi: 10.1186/s10020-025-01296-1.
2
Association between Parathyroid Hormone Concentration and Incident Atrial Fibrillation in Older Persons with Kidney Failure Initiating Dialysis.开始透析的老年肾衰竭患者甲状旁腺激素浓度与新发房颤之间的关联
Am J Nephrol. 2025 May 5:1-11. doi: 10.1159/000546266.
3
Increased risk of recurrent stroke in patients with impaired kidney function: results of a pooled analysis of individual patient data from the MICON international collaboration.肾功能受损患者复发性中风风险增加:来自MICON国际合作项目个体患者数据的汇总分析结果
J Neurol Neurosurg Psychiatry. 2025 Apr 24. doi: 10.1136/jnnp-2024-335110.
4
Anticoagulation Strategies for Atrial Fibrillation in CKD Stage G5 and Dialysis Patients: An Updated Scoping Review.慢性肾脏病5期及透析患者心房颤动的抗凝策略:最新综述
Rev Cardiovasc Med. 2025 Mar 5;26(3):26736. doi: 10.31083/RCM26736. eCollection 2025 Mar.
5
Kidney function, uric acid, and risk of atrial fibrillation: experience from the AMORIS cohort.肾功能、尿酸与心房颤动风险:来自 AMORIS 队列的经验。
BMC Cardiovasc Disord. 2024 Oct 22;24(1):581. doi: 10.1186/s12872-024-04236-9.
6
SDMA as a marker and mediator in cerebrovascular disease.SDMA 在脑血管病中的标志物和介质作用。
Clin Sci (Lond). 2024 Oct 16;138(20):1305-1323. doi: 10.1042/CS20241021.
7
Effect of impaired kidney function on outcomes and treatment effects of oral anticoagulant regimes in patients with atrial fibrillation in a real-world registry.肾功能受损对真实世界登记研究中房颤患者口服抗凝治疗结局和疗效的影响。
PLoS One. 2024 Sep 23;19(9):e0310838. doi: 10.1371/journal.pone.0310838. eCollection 2024.
8
Inverse association between serum chloride levels and the risk of atrial fibrillation in chronic kidney disease patients.慢性肾病患者血清氯水平与房颤风险之间的负相关关系。
Clin Kidney J. 2024 May 13;17(8):sfae137. doi: 10.1093/ckj/sfae137. eCollection 2024 Aug.
9
Anticoagulation in Chronic Kidney Disease.慢性肾脏病的抗凝治疗。
Drugs. 2024 Oct;84(10):1199-1218. doi: 10.1007/s40265-024-02077-6. Epub 2024 Aug 9.
10
Atrial Fibrillation and Chronic Kidney Disease: Aetiology and Management.心房颤动与慢性肾脏病:病因与管理
Rev Cardiovasc Med. 2024 Apr 9;25(4):143. doi: 10.31083/j.rcm2504143. eCollection 2024 Apr.

本文引用的文献

1
Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)中基线及随访期间的心房颤动。
J Am Coll Cardiol. 2009 Nov 24;54(22):2023-31. doi: 10.1016/j.jacc.2009.08.020.
2
Atrial fibrillation and ethnicity: the known, the unknown and the paradox.心房颤动与种族:已知、未知与矛盾之处
Future Cardiol. 2009 Nov;5(6):547-56. doi: 10.2217/fca.09.49.
3
Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study.慢性肾脏病与心房颤动之间的密切双向关系:新潟预防医学研究
Am Heart J. 2009 Oct;158(4):629-36. doi: 10.1016/j.ahj.2009.06.031.
4
The sensitivity of the method used to detect atrial fibrillation in population studies affects group-specific prevalence estimates: ethnic and regional distribution of atrial fibrillation in the REGARDS study.在人群研究中用于检测心房颤动的方法的敏感性会影响特定群体的患病率估计:REGARDS研究中心房颤动的种族和地区分布
J Epidemiol. 2009;19(4):177-81. doi: 10.2188/jea.je20081032. Epub 2009 Jun 27.
5
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.慢性肾功能不全队列(CRIC)研究:基线特征及其与肾功能的关联
Clin J Am Soc Nephrol. 2009 Aug;4(8):1302-11. doi: 10.2215/CJN.00070109. Epub 2009 Jun 18.
6
Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.白人和非裔美国人中心房颤动的发病率:社区动脉粥样硬化风险(ARIC)研究
Am Heart J. 2009 Jul;158(1):111-7. doi: 10.1016/j.ahj.2009.05.010.
7
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.心房颤动风险评分的开发(弗雷明汉心脏研究):一项基于社区的队列研究。
Lancet. 2009 Feb 28;373(9665):739-45. doi: 10.1016/S0140-6736(09)60443-8.
8
Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study.社区动脉粥样硬化风险(ARIC)研究中房颤心电图预测指标的种族分布及其对理解缺血性卒中种族分布的影响。
Stroke. 2009 Apr;40(4):1204-11. doi: 10.1161/STROKEAHA.108.534735. Epub 2009 Feb 12.
9
The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.身体活动与亚临床动脉粥样硬化之间的关联:动脉粥样硬化的多民族研究
Am J Epidemiol. 2009 Feb 15;169(4):444-54. doi: 10.1093/aje/kwn350. Epub 2008 Dec 15.
10
Evaluating the accuracy of an aneroid sphygmomanometer in a clinical trial setting.在临床试验环境中评估无液血压计的准确性。
Am J Hypertens. 2009 Mar;22(3):263-6. doi: 10.1038/ajh.2008.338. Epub 2008 Dec 4.

慢性肾脏病与常见的心房颤动:慢性肾脏病预后队列研究(CRIC)。

Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).

机构信息

Department of Epidemiology, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC 27104, USA.

出版信息

Am Heart J. 2010 Jun;159(6):1102-7. doi: 10.1016/j.ahj.2010.03.027.

DOI:10.1016/j.ahj.2010.03.027
PMID:20569726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2891979/
Abstract

BACKGROUND

The epidemiology of atrial fibrillation (AF) has been mainly investigated in patients with end-stage renal disease, with limited data on less advanced chronic kidney disease (CKD) stages.

METHODS

A total of 3,267 adult participants (50% non-Hispanic blacks, 46% women) with CKD from the Chronic Renal Insufficiency Cohort were included in this study. None of the study participants had been on dialysis. Those with self-identified race/ethnicity other than non-Hispanic black or white (n = 323) or those without electrocardiographic data (n = 22) were excluded. Atrial fibrillation was ascertained by a 12-lead electrocardiogram and self-report. Age-, sex-, and race/ethnicity-specific prevalence rates of AF were estimated and compared between subgroups. Cross-sectional associations and correlates with prevalent AF were examined using unadjusted and multivariable-adjusted logistic regression analysis.

RESULTS

The mean estimated glomerular filtration rate was 43.6 (+/-13.0) mL/(min 1.73 m(2)). Atrial fibrillation was present in 18% of the study population and in >25% of those > or =70 years old. In multivariable-adjusted models, 1-SD increase in age (11 years) (odds ratio 1.27, CI 95% 1.13-1.43, P < .0001), male [corrected] sex (0.80, 0.65-0.98, P = .0303), smoking (former vs never) (1.34, 1.08-1.66, P = .0081), history of heart failure (3.28, 2.47-4.36, P < .001), and history of cardiovascular disease (1.94, 1.56-2.43, P < .0001) were significantly associated with AF. Race/ethnicity, hypertension, diabetes, body mass index, physical activity, education, high-sensitivity C-reactive protein, total cholesterol, and alcohol intake were not significantly associated with AF. An estimated glomerular filtration rate <45 mL/(min 1.73 m(2)) was associated with AF in an unadjusted model (1.35, 1.13-1.62, P = .0010), but not after multivariable adjustment (1.12, 0.92-1.35, P = .2710).

CONCLUSIONS

Nearly 1 in 5 participants in Chronic Renal Insufficiency Cohort, a national study of CKD, had evidence of AF at study entry, a prevalence similar to that reported among patients with end-stage renal disease and 2 to 3 times of that reported in the general population. Risk factors for AF in this CKD population do not mirror those reported in the general population.

摘要

背景

心房颤动(AF)的流行病学主要在终末期肾病患者中进行了研究,关于慢性肾脏病(CKD)早期阶段的数据有限。

方法

本研究共纳入了来自慢性肾功能不全队列的 3267 名成年参与者(50%为非西班牙裔黑人,46%为女性)。研究中没有参与者接受过透析治疗。那些自我认定的种族/民族不属于非西班牙裔黑人或白人(n=323)或没有心电图数据(n=22)的人被排除在外。心房颤动通过 12 导联心电图和自我报告来确定。根据年龄、性别和种族/民族特异性,估计并比较了 AF 的患病率。使用未调整和多变量调整的逻辑回归分析,研究了与常见 AF 相关的横断面关联和相关因素。

结果

研究人群的平均估计肾小球滤过率为 43.6(+/-13.0)mL/(min 1.73 m(2))。研究人群中有 18%存在心房颤动,>70 岁的患者中>25%存在心房颤动。在多变量调整模型中,年龄(11 岁)每增加 1-SD(比值比 1.27,95%置信区间 1.13-1.43,P<.0001)、男性[纠正]性别(0.80,0.65-0.98,P=0.0303)、吸烟(以前吸烟与从不吸烟)(1.34,1.08-1.66,P=0.0081)、心力衰竭史(3.28,2.47-4.36,P<.001)和心血管疾病史(1.94,1.56-2.43,P<.0001)与 AF 显著相关。种族/民族、高血压、糖尿病、体重指数、体力活动、教育、高敏 C 反应蛋白、总胆固醇和饮酒量与 AF 无显著相关性。肾小球滤过率估计值<45 mL/(min 1.73 m(2))与未调整模型中的 AF 相关(1.35,1.13-1.62,P=0.0010),但在多变量调整后无相关性(1.12,0.92-1.35,P=0.2710)。

结论

在慢性肾功能不全队列(一项针对 CKD 的全国性研究)中,近 1/5 的参与者在研究入组时存在 AF 证据,其患病率与终末期肾病患者相似,是普通人群的 2 至 3 倍。该 CKD 人群中 AF 的危险因素与普通人群中的危险因素并不相同。